Reduced Iron Stores and Its Effect on Vasovagal Syncope (Simple Faint)
Article Outline
Iron deficiency is extraordinarily common. Iron deficiency anemia is the single most common deficiency world wide.1 Within the vascular compartment, iron is primarily contained in hemoglobin and in storage forms such as ferritin and hemosiderin.2 Iron is also present in tissue-specific forms such as myoglobin. Less commonly considered is iron's vital role in enzymes such as the respiratory cytochromes, cytochrome P-450, nitric oxide (NO) synthases, tyrosine hydroxylase providing for catecholamine synthesis, and carotid body oxygen sensors.2 These are present throughout the blood and body and are essential for life. Such “specialized” iron increases and decreases with the amount of iron storage forms and can precede overt iron deficiency.3 A decrease in iron stores usually precedes and predicts future overt iron deficiency anemia even as early as at birth where it relates to the level of maternal iron stores.4 Decreased ferritin is the usual perinatal predictor, but its predictive ability is hampered by its role as an acute-phase reactant.5 Thus, in this issue of The Journal, Baumann-Blackmore et al6 have compared a newer tool for measuring iron status, cord blood zinc protoporphyrin/heme ratio, which is insensitive to inflammatory stimuli yet correlated with ferritin in the neonate without inflammation. Although the article does not directly relate measures of neonatal iron stores to anemia or to diminished iron stores later in life, such relationships have already been established.7 These observations offer an important and sensitive new tool to the assessment of iron stores in the neonatal period.
See related articles, p 40 and p 133
Once iron deficiency is present, what are its pathophysiological consequences? It is perhaps redundant to state that aerobic metabolism depends on the delivery of oxygenated blood to the tissues. Oxygen delivery depends on hemoglobin-oxygen carrying capacity, cardiac output and its distribution, and oxygen extraction at tissue level.8 Anemia enhances oxygen extraction through a variety of mechanisms including tissue-level hypoxia, lactate, acidosis, and CO2-mediated oxygen mobilization from hemoglobin, as well as an increase in 2,3 DPG and a shift of the oxygen dissociation curve.9 Assuming distribution and use at the tissue level remains unimpaired or even enhanced in iron deficiency, the rate at which oxygen is delivered to the tissues becomes limiting.
The reduced hemoglobin-oxygen carrying capacity of iron deficiency anemia is compensated by an increase in cardiac output.10 How this is accomplished remains incompletely understood, although metabolites such as lactate, adenosine, and hydrogen ions can produce a metaboreflex response that selectively increases sympathetic outflow to the heart, increasing contractility.11 Peripheral vasoconstriction, largely the province of the arterial baroreflex, is essentially unaffected, as is the peripheral sympathetic response to orthostasis.12 Increasing cardiac contractility by itself cannot produce much of an increase in cardiac output. Increased cardiac output in iron deficiency anemia is dependent on cardiac afterload and increased venous return to the heart. Reduced viscosity13 directly caused by decreased hematocrit cannot entirely account for the low systemic resistance observed in iron deficiency anemia.
In recent years it has been demonstrated that both non-autonomic vasodilation and structural remodeling14 with increased arterial diameter are related to increased blood flow and shear stress. This is sustained by the elaboration of substances released from the vascular endothelium, specifically NO.15 NO production is increased by shear stress. However, of greater importance, hemoglobin is the preeminent scavenger of NO.16 Cell-free hemoglobin, as might occur during hemolysis,17 functions as an almost bottomless sink for NO. However, under ordinary circumstances hemoglobin is encapsulated within red blood cells, and therefore NO removal is constrained. Iron deficiency anemia can increase nitric oxide production in adolescents18 and greatly reduce its removal by virtue of decreased hemoglobin. Iron stores also scavenge NO. Reducing iron stores by chelation also improves NO-related endothelial function.19 In particular, plasma ferritin concentrations relate directly to nitric oxide mediated vasodilation and endothelial function, even in the absence of specific hemoglobin alterations.20, 21
Which brings us to consider the article by Jarjour and Jarjour.22 They performed a retrospective study that demonstrated an association between decreased serum ferritin and simple vasovagal faint. Although most of their subjects were not overtly anemic (11% vs 0% of patients in the non-simple faint group), there was a significant increase in the prevalence of low iron storage (57% vs 17%) and marked reduction of serum ferritin (27 vs 46 μg/L). Observations of apparent efficacy of iron therapy in children with decreased iron stores and breath holding spells, which may be an infantile form of acute orthostatic intolerance, are entirely consistent with these observations. Also, erythropoietin has been used with success for years in the treatment of relatively refractory forms of orthostatic intolerance, autonomic dysfunction, and simple faint.23 This study suffers from the deficits of retrospection and from the lack of healthy volunteer control subjects. Yet it is a valuable observation, pointing to a potentially crucial and simple clinical relationship between iron deficiency and fainting and indicating a simple means by which the conditions of patients with simple faint might be improved through iron supplementation. Currently, these conclusions remain speculative.
Scientific Significance—Simple Faint and No?
Why is this observation scientifically important? To date, the pathophysiological cause of simple faint remains elusive.24 The authors suggest that low iron may affect the metabolism of catecholamines, or that peripheral vasodilation prevents compensatory orthostatic vasoconstriction. Neither possibility works well because resting and upright norepinephrine is proportionate to vasoconstriction in fainters25 whereas epinephrine increases in response to hypotension.26 Anemia fails to prevent effective upright vasoconstriction.12
I propose an alternate explanation: The splanchnic circulation is the single largest reservoir of blood in the body.27 Work from our laboratory28 and others29 have shown that splanchnic pooling caused by persistent and posturally resistant splanchnic vasodilation is strongly associated with orthostatic intolerance, including vasovagal faint. Evidence suggests preferential splanchnic vasodilation in anemia,30 and NO is increased whereas nitric oxide synthesis is up-regulated in simple faint31 and in other forms of orthostatic intolerance.32 Seen in this context the dual effects of vasodilation and nitric oxide excess caused by reduced iron stores with or without anemia are highly consistent with experimental observations on the nature of simple faint. The study by Jarjour and Jarjour comprises a vital connecting piece to our understanding of simple faint in otherwise “normal” adolescents.
References
- . Food fortification strategy—preventing iron deficiency anemia: a review. Crit Rev Food Sci Nutr. 2007;47:259–265
- . Heme as key regulator of major mammalian cellular functions: molecular, cellular, and pharmacological aspects. Pharmacol Ther. 2006;111:327–345
- . Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr. 1986;6:13–40
- . Serum ferritin in children and adolescents (Results from population surveys in 1979 and 1986 comprising 1312 individuals). Eur J Haematol. 1994;53:16–20
- . Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood. 1996;87:2525–2537
- . Cord blood zinc protoporphyrin/heme ratio in minority neonates at-risk for iron deficiency. J Pediatr. 2008;153:133–136
- . Iron deficiency in infancy: applying a physiologic framework for prediction. Am J Clin Nutr. 2006;84:1412–1421
- . Physiologic aspects of anemia. Crit Care Clin. 2004;20:187–212
- . The interrelationships between red blood cell metabolites, hemoglobin, and the oxygen-equilibrium curve. Prog Hematol. 1971;7:33–67
- . The cardiac output in patients with chronic anemia as measured by the technique of right atrial catheterization. J Clin Invest. 1945;24:332–336
- Muscle metaboreflex-induced increases in cardiac sympathetic activity vasoconstrict the coronary vasculature. J Appl Physiol. 2007;103:190–194
- . The hemodynamic response to chronic anemia. Circulation. 1969;39:503–515
- . Effects of blood viscosity on hemodynamic responses in acute normovolemic anemia. Am J Physiol. 1969;216:638–642
- . Pathophysiology of anaemia: focus on the heart and blood vessels. Nephrol Dial Transplant. 2000;15(Suppl 3):14–18
- . Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1–21
- . The mechanisms by which haemoglobin inhibits the relaxation of rabbit aorta induced by nitrovasodilators, nitric oxide, or bovine retractor penis inhibitory factor. Br J Pharmacol. 1986;89:563–571
- . The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293:1653–1662
- . Iron deficiency anemia increases nitric oxide production in healthy adolescents. Ann Hematol. 2002;81:1–6
- Iron chelation improves endothelial function in patients with coronary artery disease. Circulation. 2001;103:2799–2804
- Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol. 2002;40:2189–2194
- . Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care. 2002;25:2249–2255
- . Low iron storage in children and adolescents with neurally mediated syncope. J Pediatr. 2008;153:40–44
- . Drug treatment of orthostatic hypotension and vasovagal syncope. Heart Dis. 2003;5:49–64
- . The elusive pathophysiology of neurally mediated syncope [In Process Citation]. Circulation. 2000;102:2898–2906
- . Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope. Europace. 2003;5:65–70
- Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. Am J Cardiol. 1994;73:33–37
- . Reflex control of splanchnic blood volume in anaesthetized dogs. J Physiol. 1998;513(Pt 1):263–272
- . Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation. 2004;110:2575–2581
- Splanchnic-mesenteric capacitance bed in the postural tachycardia syndrome (POTS). Auton Neurosci. 2000;86:107–113
- . Influence of normovolemic anemia on Doppler-derived blood velocity ratios of abdominal splanchnic vessels in clinically normal dogs. Vet Radiol Ultrasound. 2005;46:427–433
- Sympathetic withdrawal and forearm vasodilation during vasovagal syncope in humans. J Appl Physiol. 1997;82:1785–1793
- . Upregulation of NOS by simulated microgravity, potential cause of orthostatic intolerance. J Appl Physiol. 2000;89:338–344
PII: S0022-3476(08)00202-3
doi:10.1016/j.jpeds.2008.03.010
© 2008 Mosby, Inc. All rights reserved.
Refers to article:
- Low Iron Storage in Children and Adolescents with Neurally Mediated Syncope , 20 March 2008
- Cord Blood Zinc Protoporphyrin/Heme Ratio in Minority Neonates at Risk for Iron Deficiency
